Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "Benefits"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"Canadian Agency for Drugs and Technologies in Health"
dewey-ones:"330 - Economics"
language:"English"
Showing
161
-
180
of
231
Search:
'"Benefits"'
,
query time: 0.01s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
161
CADTH Canadian Drug Expert Committee recommendation: Lixisenatide (Adlyxine -- Sanofi-Aventis Canada inc.) : indication : diabetes mellitus, type 2
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
162
Curosurf (poractant alfa) for the treatment of infants at risk for or experiencing respiratory distress syndrome : a review of clinical effectiveness, cost-effectiveness, and guide...
by
Chao, Yi-Sheng
,
Grobelna, Aleksandra
Published 2018
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
163
Pharmacoeconomic review report: Emtricitabine/tenofovir alafenamide (Descovy)
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
164
Pharmacoeconomic review report: Lumacaftor/Ivacaftor (Orkambi) (Vertex pharmaceuticals (Canada) Incorporated) : indication, for the treatment of cystic fibrosis in patients 6 years...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
165
Methoxyflurane for acute pain in the emergency department : a review of clinical effectiveness, cost-effectiveness and guidelines
by
Wells, Charlotte
,
Adcock, Lorna
Published 2018
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
166
Bowel preparation for elective colorectal procedures : a review of clinical effectiveness, cost-effectiveness, and guidelines
by
Khangura, Sara
,
La Fleur, Philip
,
Argáez, Charlene
,
Adcock, Lorna
Published 2018
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
167
Axicabtagene ciloleucel for diffuse large B-cell lymphoma: Economic review report
Published 2019
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
168
High dose influenza vaccine for adults : a review of clinical effectiveness, cost-effectiveness, and guidelines
by
Wells, Charlotte
,
Grobelna, Aleksandra
Published 2019
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
169
CADTH Canadian Drug Expert Committee recommendation: Migalastat (Galafold -- Amicus therapeutics) : indication : Fabry disease
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
170
Pharmacoeconomic review report: Glecaprevir / pibrentasvir (Maviret) (AbbVie corporation)
Published 2018
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
171
High dose influenza vaccine for adults : a review of clinical effectiveness, cost-effectiveness, and guidelines
by
Wells, Charlotte
,
Grobelna, Aleksandra
Published 2019
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
172
Pharmacoeconomic review report: Belimumab (Benlysta) (GlaxoSmithKline Inc.) : indication: indicated in addition to standard therapy for reducing disease activity in adult patients...
Published 2020
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
173
Pharmacoeconomic report: Vedolizumab (Entyvio SC) Takeda Canada Inc. : indication : for the treatment of adult patients with moderately to severely active ulcerative colitis who ha...
Published 2020
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
174
Pharmacoeconomic review report: Ocrelizumab (Ocrevus) (Hoffmann-La roche limited)
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
175
Pharmacoeconomic review report: Empagliflozin (Jardiance)
Published 2015
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
176
Magnetic resonance imaging for prostate assessment : a review of clinical and cost-effectiveness
by
Chiu, Stephanie
,
Adcock, Lorna
Published 2018
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
177
Pharmacoeconomic review report: Empagliflozin (Jardiance)
Published 2015
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
178
Ceftolozane and tazobactam for the treatment of bacterial infections : a review of clinical effectiveness, cost-effectiveness, and guidelines
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
179
Pharmacoeconomic review report: Dolutegravir/Lamivudine (Dovato) (ViiV healthcare ULC) : indication: as a complete regimen for the treatment of human immunodeficiency virus type1 (...
Published 2019
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
180
Pharmacoeconomic review report: Netupitant/Palonosetron 300 mg/0.5 mg (Akynzeo) (Purdue pharma)
Published 2018
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
2
3
4
5
6
7
8
9
10
11
12
Back
Narrow Search
Remove Filters
Clear Filter
Author: Canadian Agency for Drugs and Technologies in Health
Clear Filter
Classification: 330 - Economics
Clear Filter
Language: English
Year of Publication
From:
To:
Classification
330 - Economics
610 - Medicine & health
76
140 - Specific philosophical schools
19
700 - The arts; fine & decorative arts
17
580 - Plants (Botany)
3
600 - Technology
2
more ...
615 - Pharmacology & therapeutics
2
100 - Philosophy & psychology
1
363 - Other social problems & services
1
800 - Literature & rhetoric
1
see all ...
less ...
Language
English
Collection
National Center for Biotechnology Information
231
Author
Canadian Agency for Drugs and Technologies in Health
CADTH Canadian Drug Expert Committee
50
Canadian Agency for Drugs and Technologies in Health Rapid Response Service
27
Adcock, Lorna
7
Ho, Chuong
7
Ford, Caitlyn
6
more ...
Grobelna, Aleksandra
5
Argáez, Charlene
4
Chao, Yi-Sheng
4
Gray, Casey
4
McCormack, Suzanne
4
Tran, Khai
4
Banerjee, Srabani
3
Campbell, Kaitryn
3
Loshak, Hannah
3
MacDougall, Danielle
3
Wells, Charlotte
3
Williams, D.
3
Young, Calvin
3
Farrah, Kelly
2
Frey, Nina
2
Jahagirdar, Deepa
2
Kanga, Ismat
2
Poitras, Veronica
2
Visintini, Sarah
2
Adams, Alison
1
Chiu, Stephanie
1
Cowling, Tara
1
De Nanassy, Alina
1
Edge, Rob
1
Harricharan, Sharada
1
Khangura, Sara
1
Klarenbach, Scott
1
Krahn, Murray
1
La Fleur, Philip
1
Lachance, Chantelle
1
Lee, Karen M.
1
Marchand, Dave K.
1
Membe, Stephen K.
1
Narain, Tasha
1
Palylyk-Colwell, Eugenia
1
Picheca, Lory
1
Singh, Sumeet
1
Spry, Carolyn
1
Thompson, Wade
1
Wong, William
1
Wright, Mary-Doug
1
Yeung, Shirley S. T.
1
see all ...
less ...
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?page=9&filter%5B%5D=author_facet%3A%22Canadian+Agency+for+Drugs+and+Technologies+in+Health%22&filter%5B%5D=dewey-ones%3A%22330+-+Economics%22&filter%5B%5D=language%3A%22English%22&lookfor=%22Benefits%22&type=Subject
Send by Email
×
Loading...